L. Sui

Multicentre, prospective, randomised controlled trial to evaluate hexaminolevulinate photodynamic therapy (Cevira) as a novel treatment in patients with high-grade squamous intraepithelial lesion: APRICITY phase 3 study protocol

P. Hillemanns, L. Sui, Youzhong Zhang, 2021, BMJ Open.

[Distant Metastasis and Survival Outcomes after Computed Tomography-guided Needle Biopsy in Stage I-II Non-small Cell Lung Cancer].

Jing Hu, Jingli Fan, Keke Zhai, 2017, Zhongguo fei ai za zhi = Chinese journal of lung cancer.

Therapeutic effect of thalidomide combined with temozolomide and three-dimensional conformal radiotherapy for patients with high-grade gliomas after operation.

L. Sui, Yuzhen Li, Zhiying Xu, 2020, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.

Knockdown of TRIM44 inhibits the progression of ovarian cancer and is related to the FOXM1-EZH2 signaling pathway

F. Meng, Yuanlong Hu, L. Sui, 2022, Translational cancer research.